MedPath

Changes in Interleukin-35 levels in Gingival crevicular fluid before and after Non-surgical periodontal therapy

Phase 1
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2020/04/024656
Lead Sponsor
none
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group I: Periodontally healthy patients with no clinical attachment loss (CAL), probing pocket

depth (PPD) < 3 mm, and PBI score < 1.

Group II: Gingivitis patients, who show clinical signs of gingival inflammation and also showing

no clinical attachment loss, Probing pocket Depth (PPD) <= 3 mm, and PBI score > 1.

Group III: Stage III periodontitis patients who will be identified according to the clinical signs of periodontitis.

Exclusion Criteria

1. Systemic diseases that could affect the periodontium.

2. Tobacco (in any form) and alcoholics.

3. Pregnant or lactating females.

4. Periodontal treatment received in the past 6 months.

5. Use of anti-inflammatory and antibiotic drugs in past 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath